BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 22025782)

  • 1. Continued reduction in the prevalence of retinopathy in adolescents with type 1 diabetes: role of insulin therapy and glycemic control.
    Downie E; Craig ME; Hing S; Cusumano J; Chan AK; Donaghue KC
    Diabetes Care; 2011 Nov; 34(11):2368-73. PubMed ID: 22025782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002.
    Mohsin F; Craig ME; Cusumano J; Chan AK; Hing S; Lee JW; Silink M; Howard NJ; Donaghue KC
    Diabetes Care; 2005 Aug; 28(8):1974-80. PubMed ID: 16043741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve Abnormality.
    Zabeen B; Craig ME; Virk SA; Pryke A; Chan AK; Cho YH; Benitez-Aguirre PZ; Hing S; Donaghue KC
    PLoS One; 2016; 11(4):e0153033. PubMed ID: 27050468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study.
    Rosenlund S; Hansen TW; Andersen S; Rossing P
    Diabet Med; 2015 Nov; 32(11):1445-52. PubMed ID: 26331364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006.
    Cho YH; Craig ME; Hing S; Gallego PH; Poon M; Chan A; Donaghue KC
    Pediatr Diabetes; 2011 Dec; 12(8):682-9. PubMed ID: 21435138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion is more effective than multiple daily insulin injections in preventing albumin excretion rate increase in Type 1 diabetic patients.
    Lepore G; Bruttomesso D; Bonomo M; Dodesini AR; Costa S; Meneghini E; Corsi A; Nosari I; Trevisan R
    Diabet Med; 2009 Jun; 26(6):602-8. PubMed ID: 19538235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.
    Olsen BS; Sjølie A; Hougaard P; Johannesen J; Borch-Johnsen K; Marinelli K; Thorsteinsson B; Pramming S; Mortensen HB
    J Diabetes Complications; 2000; 14(6):295-300. PubMed ID: 11120452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved glycemic control with use of continuous subcutaneous insulin infusion compared with multiple insulin injection therapy.
    Bell DS; Ovalle F
    Endocr Pract; 2000; 6(5):357-60. PubMed ID: 11141585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.
    Rizvi AA; Petry R; Arnold MB; Chakraborty M
    Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.
    Jakisch BI; Wagner VM; Heidtmann B; Lepler R; Holterhus PM; Kapellen TM; Vogel C; Rosenbauer J; Holl RW;
    Diabet Med; 2008 Jan; 25(1):80-5. PubMed ID: 18199134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.